Questions and answers – Complex clinical trials
This Q&A document provides guidance and seeks to support sponsors, clinical trialists and applicants regarding scientific aspects and the planning, set-up, submission for obtaining CT authorisation (CTA), conduct, reporting and transparency, analysis and interpretation of complex clinical trials (CCTs) under the EU Clinical Trials Regulation (EU CTR) as well as their use in submissions for marketing authorisation.
Read the news announcement published by EC Directorate-General for Health and Food Safety on 2 June 2022.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (25 juillet 2022). Questions and answers – Complex clinical trials. ELSIBI. Consulté le 18 février 2026 à l’adresse https://doi.org/10.58079/o613





